(Q47923705)

6 February 2018

title

Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments (English)

1 reference

6 February 2018

author

Dirk Roggenbuck

6

1 reference

6 February 2018

author name string

Küttner G

1

1 reference

6 February 2018

Kramer A

2

1 reference

6 February 2018

Schmidtke G

3

1 reference

6 February 2018

Giessmann E

4

1 reference

6 February 2018

Dong L

5

1 reference

6 February 2018

Scholz C

7

1 reference

6 February 2018

Seifert M

8

1 reference

6 February 2018

Stigler RD

9

1 reference

6 February 2018

Schneider-Mergener J

10

1 reference

6 February 2018

Porstmann T

11

1 reference

6 February 2018

Höhne W

12

1 reference

6 February 2018

publication date

1 July 1999

1 reference

6 February 2018

published in

Molecular Immunology

1 reference

6 February 2018

volume

36

1 reference

6 February 2018

issue

10

1 reference

6 February 2018

page(s)

669-683

1 reference

6 February 2018

Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Canonical structures for the hypervariable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Conformations of immunoglobulin hypervariable regions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Making antibody fragments using phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Mapping of linear B-cell epitopes of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Studies on the attachment and penetration of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within PreS1 of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

IMGT, the international ImMunoGeneTics database

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Errors in protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Rapid PCR-cloning of full-length mouse immunoglobulin variable regions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Engineered turns of a recombinant antibody improve its in vivo folding

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

A phage library-derived single-chain Fv fragment in complex with turkey egg-white lysozyme: characterization, crystallization and preliminary X-ray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Epitope mapping of the PreS1 domain of the hepatitis B virus large surface protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Analysis by surface plasmon resonance of the influence of valence on the ligand binding affinity and kinetics of an anti-carbohydrate antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Hepatitis B virus contains pre-S gene-encoded domains

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

HepG2 cell binding activities of different hepatitis b virus isolates: inhibitory effect of anti-HBs and anti-preS1(21–47)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Humanization of murine monoclonal antibodies through variable domain resurfacing

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Influence of solid-phase antigen in competition enzyme-linked immunosorbent assays (ELISAs) on calculated antigen-antibody dissociation constants

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of Hepatitis B virus to hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Variable protein composition of hepatitis B surface antigen from different donors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

WHAT IF: a molecular modeling and drug design program

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Maltodextrin-binding protein hybrids carrying epitopes from the preS2 region of hepatitis B virus: expression, antibody-binding and preliminary crystallographic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

A new method for computing the macromolecular electric potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

Optimization of primer sequences for mouse scFv repertoire display library construction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900074-7

7 January 2021

10.1016/S0161-5890(99)00074-7

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018